Full-Time

Associate Director

Program Management, Infectious Disease

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • BS degree in a scientific field with a minimum of 10 years of experience or MS degree in a scientific field with 6-8 years of experience in a biotechnology or pharmaceutical setting.
  • Proven track record of successful project management experience in drug development (preferably in Infectious Diseases) across multiple phases (pre-clinical and clinical Phase 1-3).
  • Prior experience managing or working within cross-functional project teams with timeline management and budgetary responsibility.
  • Strong knowledge of project management tools and software (e.g., Smartsheet, MS Project, and timeline visualization software).
  • Must be adept at working in a fluid environment and foster a strong collaborative spirit internally and externally.
  • Strong personal skills to influence without authority, motivate others and manage conflict.
  • Strong written and oral communication skills as well as demonstrated organizational aptitude.
  • Preferred: Project/program management training.
  • Preferred: Ph.D. or PharmD and 2+ years of experience in a biotechnology or pharmaceutical setting.
  • Preferred: Laboratory experience in an academic or biotechnology setting.
Responsibilities
  • Partnering with the program leader to shape program strategy and execution plan.
  • Collaborating with functional leads to define program strategy and proactively identify and escalate gaps and challenges; Managing team through scenario planning to solve problems.
  • Building relationships with key stakeholders (team members and leadership) to ensure alignment of functional and corporate objectives; Leveraging organizational dynamics to promote program goals.
  • Coordinating team efforts to develop impactful presentations to summarize complex topics into critical points to facilitate strategic planning and decision-making, Preparing program status updates and governance presentations to the Development Review Committee (DRC) and Executive Committee.
  • Developing and tracking activities against program timelines and budget.
  • Administering the day-to-day activities, including, facilitating cross-functional team meetings, leading discussions to drive decision-making, preparing agenda and meeting minutes, and defining and resolving action items.
  • Working with the Finance group to implement and track the program budget.
  • Contributing to Program Management initiatives to support the development and scaling of capabilities, tools, and processes.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?